Search

Your search keyword '"Fasching, P.A."' showing total 62 results

Search Constraints

Start Over You searched for: Author "Fasching, P.A." Remove constraint Author: "Fasching, P.A." Database OpenAIRE Remove constraint Database: OpenAIRE
62 results on '"Fasching, P.A."'

Search Results

1. FANCM missense variants and breast cancer risk

2. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis

3. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in similar to 200,000 patients (vol 24, 69, 2022)

4. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

5. A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)

6. Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

7. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

8. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

9. Efficacy and safety of ribociclib (RIB) in combination with letrozole (LET) in patients with estrogen receptor–positive advanced breast cancer (ABC) : Secondary and exploratory results of phase 3b RIBECCA study

11. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

12. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

13. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

14. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

15. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

16. Two truncating variants in FANCC and breast cancer risk

17. Genome-wide association study of germline variants and breast cancer-specific mortality

18. Genome-wide association study of germline variants and breast cancer-specific mortality

19. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

20. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

21. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (vol 5, 4999, 2014)

22. Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium\ud

23. Supplementary Material for: Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study

24. Gene-environment interactions involving functional variants

25. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

26. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

27. Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen receptor positive breast cancer through FGF10 and MRPS30 regulation

28. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

29. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

30. Genetic predisposition to ductal carcinoma in situ of the breast

31. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

32. The Clinical Data Intelligence Project

33. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

34. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

35. SNP-SNP interaction analysis of NF-kappa B signaling pathway on breast cancer survival

36. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

37. SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival

38. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

39. Identification of novel genetic markers of breast cancer survival

40. Common germline polymorphisms\ud associated with breast cancer-specific survival

41. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk

42. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2

43. Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk

44. Identification of Novel Genetic Markers of Breast Cancer Survival

46. Refined histopathological predictors of BRCA1\ud and BRCA2 mutation status: a large-scale analysis\ud of breast cancer characteristics from the BCAC,\ud CIMBA, and ENIGMA consortia

47. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

48. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

49. Genetic Predisposition to In Situ and Invasive Lobular\ud Carcinoma of the Breast

50. MicroRNA related polymorphisms and breast cancer risk

Catalog

Books, media, physical & digital resources